Sort by

Send to

Choose Destination

Links from PubMed

Items: 20


Molecular aspects of prostate cancer with neuroendocrine differentiation.

Li Q, Zhang CS, Zhang Y.

Chin J Cancer Res. 2016 Feb;28(1):122-9. doi: 10.3978/j.issn.1000-9604.2016.01.02. Review.


De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature.

Okoye E, Choi EK, Divatia M, Miles BJ, Ayala AG, Ro JY.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):9061-6. Review.


De novo large cell neuroendocrine carcinoma of the prostate, case report and literature review.

Acosta-Gonzalez G, Qin J, Wieczorek R, Melamed J, Deng FM, Zhou M, Makarov D, Ye F, Pei Z, Pincus MR, Lee P.

Am J Clin Exp Urol. 2014 Dec 25;2(4):337-42.


Neuroendocrine differentiation of prostate cancer: a review.

Parimi V, Goyal R, Poropatich K, Yang XJ.

Am J Clin Exp Urol. 2014 Dec 9;2(4):273-85. Review.


A rare case of large cell neuroendocrine carcinoma.

Lin D, Tan AJ, De Sousa AF, Singh-Rai R.

BMJ Case Rep. 2014 Oct 19;2014. pii: bcr2014206403. doi: 10.1136/bcr-2014-206403.


Large cell neuroendocrine carcinoma of the ovary: A pathologic entity in search of clinical identity.

Voutsadakis IA.

World J Clin Oncol. 2014 May 10;5(2):36-8. doi: 10.5306/wjco.v5.i2.36.


The many faces of neuroendocrine differentiation in prostate cancer progression.

Terry S, Beltran H.

Front Oncol. 2014 Mar 25;4:60. doi: 10.3389/fonc.2014.00060. Review.


Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Iyoda A, Makino T, Koezuka S, Otsuka H, Hata Y.

Gen Thorac Cardiovasc Surg. 2014 Jun;62(6):351-6. doi: 10.1007/s11748-014-0379-9. Review.


Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA.

Am J Surg Pathol. 2014 Jun;38(6):756-67. doi: 10.1097/PAS.0000000000000208.


Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J.

Asian J Androl. 2014 Jul-Aug;16(4):541-4. doi: 10.4103/1008-682X.123669. Review.


Small cell carcinoma of the prostate.

Nadal R, Schweizer M, Kryvenko ON, Epstein JI, Eisenberger MA.

Nat Rev Urol. 2014 Apr;11(4):213-9. doi: 10.1038/nrurol.2014.21. Review.


A case of the large cell neuroendocrine carcinoma of the urinary bladder.

Hata S, Tasaki Y.

Case Rep Med. 2013;2013:804136. doi: 10.1155/2013/804136.


Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.

Colarossi C, Pino P, Giuffrida D, Aiello E, Costanzo R, Martinetti D, Memeo L.

Diagn Pathol. 2013 Feb 4;8:19. doi: 10.1186/1746-1596-8-19.


Prostatic metastasis of pulmonary large cell neuroendocrine carcinoma.

Shimizu K, Goto T, Maeshima A, Oyamada Y, Kato R.

J Cancer. 2012;3:96-9. doi: 10.7150/jca.3770.


Modeling a lethal prostate cancer variant with small-cell carcinoma features.

Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, Hoang A, Efstathiou E, Sircar K, Navone NM, Troncoso P, Liang S, Logothetis CJ, Maity SN, Aparicio AM.

Clin Cancer Res. 2012 Feb 1;18(3):666-77. doi: 10.1158/1078-0432.CCR-11-1867.


Review of small cell carcinomas of the prostate.

Furtado P, Lima MV, Nogueira C, Franco M, Tavora F.

Prostate Cancer. 2011;2011:543272. doi: 10.1155/2011/543272.


Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.

Aparicio A, Tzelepi V, Araujo JC, Guo CC, Liang S, Troncoso P, Logothetis CJ, Navone NM, Maity SN.

Prostate. 2011 Jun 1;71(8):846-56. doi: 10.1002/pros.21301.


Small-cell prostate carcinoma: A retrospective analysis of five newly reported cases.

Brownback KR, Renzulli J, Delellis R, Myers JR.

Indian J Urol. 2009 Apr;25(2):259-63. doi: 10.4103/0970-1591.52940.


Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Gattenlöhner S, Stühmer T, Leich E, Reinhard M, Etschmann B, Völker HU, Rosenwald A, Serfling E, Bargou RC, Ertl G, Einsele H, Müller-Hermelink HK.

Am J Pathol. 2009 Apr;174(4):1160-71. doi: 10.2353/ajpath.2009.080647.


Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.

Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Eisenberger M, Nelson WG, Mostwin JL, De Marzo AM.

Prostate. 2009 May 1;69(6):603-9. doi: 10.1002/pros.20910.

Items per page

Supplemental Content

Support Center